Los puntos clave no están disponibles para este artículo en este momento.
The development of multicancer early detection tests has surged in recent years. When evaluating such tests, it will be important to maintain a high bar for concluding that there is evidence of benefit.
Hilary A. Robbins (Sat,) studied this question.